Topic
Oncology
342 Podcasts • 88 Cases • 19 Courses on BackTable
Hear how experienced clinicians in Oncology approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 76 • 11 Aug 2026
GU Oncology: ASCO Highlights & Impacts on Practice
Is GU oncology entering a new era of early intensification and precision therapy? On this episode of the BackTable Tumor Board Podcast, Dr. Katy Beckermann and Dr. Alan Tan break down the latest GU oncology highlights from ASCO, including key updates in prostate, renal cell, and urothelial carcinoma. They discuss new data supporting HRR/BRCA-focused therapy in HSPC, the importance of early biomarker testing, and ongoing debates about overtreatment and real-world practice impact.
More on Oncology
Loading recent podcasts…
Tumor Board # 76
Aug 11, 2026
with Dr. Alan Tan, Dr. Katy Beckermann
Is GU oncology entering a new era of early intensification and precision therapy? On this episode of the BackTable...
Tumor Board # 75
Aug 4, 2026
with Dr. Cathy Eng, Dr. Jun Gong
Is it time to rethink the definition of “cure” for stage IV colorectal cancer? In this episode of BackTable Tumor...
110+ listens
Tumor Board # 74
Jul 28, 2026
with Dr. Chih-Yi Liao, Dr. Robert Ramirez, Dr. Lingling Du
What first-line therapies should be considered for patients with higher-grade, metastatic neuroendocrine tumors (NETs)?...
110+ listens
Vascular & IR # 665
Jul 21, 2026
with Dr. Peter Thurlow, Dr. Neil Jain
A bone biopsy can reach the target and still miss the diagnosis. In this episode of the BackTable Podcast, host Dr....
1,400+ listens
Urology # 323
Aug 11, 2026
with Dr. Charles Peyton, Dr. Ruchika Talwar
Recurrent low-grade, intermediate-risk bladder cancer presents a unique treatment challenge: recurrence is common,...
Urology # 320
Jul 31, 2026
with Dr. Sarah Psutka, Dr. Ruchika Talwar
Can a drug-eluting bladder device change the treatment algorithm for BCG-unresponsive non–muscle invasive bladder...
850+ listens
Tumor Board # 73
Jul 21, 2026
with Dr. Lindsay Peterson, Dr. Kate Baker
When breast cancer treatment ends, recurrence surveillance can easily overshadow the symptoms and concerns that...
150+ listens
Bone & Sports # 106
Jul 21, 2026
with Dr. Peter Thurlow, Dr. Neil Jain
A bone biopsy can reach the target and still miss the diagnosis. In this episode of the BackTable Podcast, host Dr....
270+ listens
VI Case
Jul 28, 2026
with Dr. Trushar Patel and Dr. Sabeen Dhand
Tumor Board Case
Aug 17, 2026
with Dr. Chih-Yi Liao, Dr. Xavier Keutgen and Dr. Lingling Du
VI Case
Apr 30, 2026
with Dr. Christopher Malone, Dr. Kirema Garcia-Reyes and Dr. Venkatesh Krishnasamy
VI Case
Jun 16, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jul 27, 2026
with Dr. Abhishek Kumar (VIR) and Dr. Sabeen Dhand
VI Case
Jun 16, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 16, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 16, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
Tumor Board Course
2 CME/CE credits, 2.5 hours, 26 lessons
Urology Course
3 hours, 28 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.